A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy
Phenotypic testing predicts virological response in successive protease inhibitor-based regimens
Once-daily dosing of saquinavir and low-dose ritonavir in HIV-1-infected individuals: a pharmacokinetic pilot study
Role of CD38 in HIV-1 infection: an epiphenomenon of T-cell activation or an active player in virus/host interactions?
Prevention of infectious complications of paediatric HIV infection in Africa
Quantitative evaluation of the recombinant HIV-1 phenotype to protease inhibitors by a single-step strategy
Evolution of lamivudine-resistant hepatitis B virus and HIV-1 in co-infected individuals: an analysis of the CAESAR study
Absence of specific mucosal antibody responses in HIV-exposed uninfected sex workers from the Gambia
The restricted cellular host range of human herpesvirus 8
Effect of clinical events on plasma HIV-1 RNA levels in persons with CD4+ T-lymphocyte counts of more than 500 × 106 cells/l
The values of quantitative serum HIV-1 RNA levels and CD4 cell counts for predicting survival time among HIV-positive individuals with CD4 counts of ≤ 50 × 106 cells/l
Strong association between failure of T cell homeostasis and the syncytium-inducing phenotype among HIV-1-infected men in the Amsterdam Cohort Study
Changes in the natural history of cytomegalovirus retinitis following the introduction of highly active antiretroviral therapy
A randomised, open-label comparison of three highly active antiretroviral therapy regimens including two nucleoside analogues and indinavir for previously untreated HIV-1 infection: the OzCombo1 study
Efficacy and safety of twice daily first-line ritonavir/indinavir plus double nucleoside combination therapy in HIV-infected individuals
Enhanced penetration of indinavir in cerebrospinal fluid and semen after the addition of low-dose ritonavir
Absence of zidovudine resistance in antiretroviral-naive patients following zidovudine/lamivudine/protease inhibitor combination therapy: virological evaluation of the AVANTI 2 and AVANTI 3 studies
Phenotypic and genotypic analysis of clinical HIV-1 isolates reveals extensive protease inhibitor cross-resistance: a survey of over 6000 samples
Efficacy and safety of famciclovir for treating mucocutaneous herpes simplex infection in HIV-infected individuals
Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda
Antiretroviral medication use among injection drug users: two potential futures
HIV/AIDS among African Americans: progress or progression?
A randomized trial of hierarchical counseling in a short, clinic-based intervention to reduce the risk of sexually transmitted diseases in women
Cost–threshold analyses of the National AIDS Demonstration Research HIV Prevention Interventions
Differential trends in mortality from AIDS in men and women in Brazil (1984–1995)
HIV prevalence and strain diversity in Gabon: the end of a paradox
Low and stable HIV infection rates in Senegal?
Mobile phone and interactive computer interviewing to measure HIV-related risk behaviours: the impacts of data collection methods on research results
Novel SDF-1 gene mutations in simians: presence of GG–AA transition in the 3' untranslated region
Elicitation of protective immunity against simian immunodeficiency virus infection by a recombinant Sendai virus expressing the Gag protein
Isolation of Mycobacterium interjectum in an AIDS patient with diarrhea
Onset of HIV-1 antibody production after highly active antiretroviral therapy in a seronegative HIV-1-infected child
Steatosis–lactic acidosis syndrome associated with stavudine and lamivudine therapy
Induction of P-glycoprotein expression by HIV protease inhibitors in cell culture
Protease inhibitor-related paronychia, ingrown toenails, desquamative cheilitis and cutaneous xerosis
Efavirenz decreases methadone blood concentrations
Frequency of multinucleoside analogue-resistant genotypes observed during antiretroviral therapy